79% FX-adj. sales growth in Q2, mainly driven by Catalyst. Opex stabilising. Fine-tune fair value range to SEK 6-15.

04 Sep 2023
Catalyst drives impressive growth in Q2

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Catalyst drives impressive growth in Q2
- Published:
04 Sep 2023 -
Author:
ABGSC Healthcare Research | Sten Gustafsson -
Pages:
11 -
79% FX-adj. sales growth in Q2, mainly driven by Catalyst. Opex stabilising. Fine-tune fair value range to SEK 6-15.